The co-author of the study linking the active ingredient in Tylenol to increased incidence of neurodevelopmental disorders says more research is needed on the issue.
The report follows news articles that the Trump administration is expected to assert that use of acetaminophen, the active ingredient in Tylenol, can increase the risk of autism when used during pregnancy.
“Part of this framework is to evaluate the quality of the studies,” Ann Bauer, an epidemiologist and co-author of the study, told Newsweek ahead of President Donald Trump’s scheduled afternoon press conference on the topic.
Read more at Newsmax© 2025 Newsmax. All rights reserved.
